Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma

Trial Identifier: PT001101-00
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT02433834
Start Date: May 2015
Primary Completion Date: March 2016
Study Completion Date: March 2016
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, AL Birmingham, AL, US, 35209
US, CA Anaheim, CA, US, 92801
US, CA Bakersfield, CA, US, 93301
US, CA Cerritos, CA, US, 90703
US, CA Los Angeles, CA, US, 90017
US, CA Los Angeles, CA, US, 90048
US, CA Los Angeles, CA, US, 90025
US, CA Los Angeles, CA, US, 90036
US, CA Quartz Hill, CA, US, 90036
US, CA Rancho Mirage, CA, US, 92270
US, CA Rolling Hills Estates, CA, US, 90274
US, CA Stockton, CA, US, 95207
US, CO Colorado Springs, CO, US, 80907
US, FL Kissimmee, FL, US, 34744
US, FL Miami, FL, US, 33186
US, FL Miami, FL, US, 33126
US, FL Ormond Beach, FL, US, 32174
US, IA Iowa City, IA, US, 52240
US, IL Evanston, IL, US, 60201
US, MA Fall River, MA, US, 02720
US, MA North Dartmouth, MA, US, 02747
US, MO St. Louis, MO, US, 63141
US, NC Asheville, NC, US, 28801
US, NC Cornelius, NC, US, 28031
US, NC Gastonia, NC, US, 28054
US, NC Monroe, NC, US, 28112
US, NC Raleigh, NC, US, 28054
US, NC Shelby, NC, US, 28152
US, NE Omaha, NE, US, 68114
US, NJ Skillman, NJ, US, 08558
US, NJ Verona, NJ, US, 07044
US, OH Grove City, OH, US, 43123
US, OH Middleburg Heights, OH, US, 44130
US, OR Lake Oswego, OR, US, 97035
US, OR Medford, OR, US, 97504
US, SC Columbia, SC, US, 29201
US, TX Dallas, TX, US, 75254
US, TX El Paso, TX, US, 79903
US, TX Kileen, TX, US, 76543
US, TX McKinney, TX, US, 75070
US, TX New Braunfels, TX, US, 78130
US, TX San Antonio, TX, US, 78229
US, TX Waco, TX, US, 76712